Cargando…

CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6

SIMPLE SUMMARY: The atypical chemokine receptor ACKR2 plays an important role in the tumour microenvironment. It has long been considered as a scavenger of inflammatory chemokines exclusively from the CC family. In this study, we identified the CXC chemokine CXCL10 as a new strong agonist ligand for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chevigné, Andy, Janji, Bassam, Meyrath, Max, Reynders, Nathan, D’Uonnolo, Giulia, Uchański, Tomasz, Xiao, Malina, Berchem, Guy, Ollert, Markus, Kwon, Yong-Jun, Noman, Muhammad Zaeem, Szpakowska, Martyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958614/ https://www.ncbi.nlm.nih.gov/pubmed/33801414 http://dx.doi.org/10.3390/cancers13051054

Ejemplares similares

The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B
por: D’Uonnolo, Giulia, et al.
Publicado: (2022)

Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7
por: Meyrath, Max, et al.
Publicado: (2021)

The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides
por: Meyrath, Max, et al.
Publicado: (2020)

The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7
por: Szpakowska, Martyna, et al.
Publicado: (2021)

Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma
por: Isci, Damla, et al.
Publicado: (2021)

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity
por: Melgrati, Serena, et al.
Publicado: (2023)

New pairings and deorphanization among the atypical chemokine receptor family — physiological and clinical relevance
por: Szpakowska, Martyna, et al.
Publicado: (2023)

CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
por: Kouzeli, Ariadni, et al.
Publicado: (2020)

The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
por: Reynders, Nathan, et al.
Publicado: (2019)

Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target
por: Noman, Muhammad Zaeem, et al.
Publicado: (2018)

Firing up the cold tumors by targeting Vps34
por: Janji, Bassam, et al.
Publicado: (2020)

Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
por: Meyrath, Max, et al.
Publicado: (2022)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
por: Noman, Muhammad Zaeem, et al.
Publicado: (2019)

Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies
por: Xiao, Malina, et al.
Publicado: (2021)

Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34
por: Janji, Bassam, et al.
Publicado: (2020)

Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis
por: Girbl, Tamara, et al.
Publicado: (2018)

ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins
por: Matti, Christoph, et al.
Publicado: (2020)

Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst Facet
por: Viry, Elodie, et al.
Publicado: (2016)

Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
por: Lequeux, Audrey, et al.
Publicado: (2021)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

The chemokine scavenging receptor D6/ACKR2 is a target of miR-146a in thyroid cancer
por: Pacifico, Francesco, et al.
Publicado: (2017)

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
por: Xiao, Malina, et al.
Publicado: (2021)

The Duffy Antigen Receptor for Chemokines DARC/ACKR1
por: Horuk, Richard
Publicado: (2015)

Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings
por: Lewandowska, Paulina, et al.
Publicado: (2020)

The β-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation
por: Noman, Muhammad Zaeem, et al.
Publicado: (2022)

Reassessing the adrenomedullin scavenging function of ACKR3 in lymphatic endothelial cells
por: Sigmund, Elena C., et al.
Publicado: (2023)

ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
por: Bonavita, Ornella, et al.
Publicado: (2017)

Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy
por: Noman, Muhammad Zaeem, et al.
Publicado: (2020)

SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC
por: Hasmim, Meriem, et al.
Publicado: (2022)

The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
por: García-Cuesta, Eva M., et al.
Publicado: (2019)

Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity
por: Janji, Bassam, et al.
Publicado: (2018)

Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression
por: Giuliani, Massimo, et al.
Publicado: (2017)

A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022)

Corrigendum: ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
por: Bonavita, Ornella, et al.
Publicado: (2017)

Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer
por: Berchem, Guy, et al.
Publicado: (2015)

The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury
por: Woodcock, Thomas M., et al.
Publicado: (2017)

Control of Cytoskeletal Dynamics by β-Arrestin1/Myosin Vb Signaling Regulates Endosomal Sorting and Scavenging Activity of the Atypical Chemokine Receptor ACKR2
por: Vacchini, Alessandro, et al.
Publicado: (2020)

Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)
por: Bonnavion, Remy, et al.
Publicado: (2023)

Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology
por: Chatterjee, Madhumita
Publicado: (2022)

Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
por: Duval, Vincent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oulle2qf39o8kbdcdbvsktup19